Expected adaptation
Your answers suggest this may still fit a normal adaptation window. Keep tracking, avoid emotional self-adjustment, and review trend quality over the next 1-2 weeks.
Not for emergencies. Call 911 if experiencing medical emergency.
Free planning tool
Not every flat trend means the medication stopped working. Use this tool alongside the semaglutide and tirzepatide guides to review hidden blockers that make month-two or month-three stalls look worse than they are.
This tool is educational only. It does not diagnose, prescribe, or replace clinician guidance.
Your answers suggest this may still fit a normal adaptation window. Keep tracking, avoid emotional self-adjustment, and review trend quality over the next 1-2 weeks.
Your answers suggest the flatter trend may be driven by hydration, protein, bowel regularity, sleep, or symptom burden rather than immediate medication failure. Use the output summary to guide your next clinician conversation.
Your answers suggest it is reasonable to review the plateau now with a clinician, especially if the trend has stayed flat for 3-4 weeks despite strong adherence.
Your answers suggest symptoms may be the more immediate issue. This tool is not emergency care. Use your clinician's escalation instructions or seek urgent evaluation for severe or worsening symptoms.
A real plateau is usually a flatter trend that persists for at least 3 to 4 weeks while adherence, hydration, protein, and follow-up have stayed reasonably consistent.
Yes. Bowel changes, low protein intake, poor hydration, and low intake from nausea can all make progress look worse than it is.
No. Dose changes should stay clinician-guided, especially if symptoms, refill changes, or documentation questions are part of the picture.
Contact your clinician sooner if the trend has stayed flat for 3 to 4 weeks despite strong adherence, or if symptoms and refill changes are making the pattern hard to interpret.
This tool is educational only. It does not diagnose, prescribe, or replace clinician guidance.